Resources
For the latest in precision medicine, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarker Discovery & Development
New Therapeutic Target for Aggressive Breast Cancer
Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Digital Biomarkers
Digital Biomarkers for Disease Detection and Monitoring
Beverley Patterson, Clinical Science Director at Ono Pharma UK Ltd, leads a Discussion Group on harnessing biomarker technologies to improve disease detection and tracking.
Diagnostic Development
Genetic Variants Linked to Dyslexia
A new study from the University of Edinburgh has identified potential gene indications associated with dyslexia.
Diagnostic Development
Thirdhand Smoke Triggers Skin Disease
New research suggests acute exposure to thirdhand smoke elevates biomarkers associated with skin diseases.
Digital Biomarkers
Digital Biomarkers: Using Smartphones for the Passive Monitoring of Neurodegenerative Diseases
Smartphones, laptops and other household electronic devices could be optimised for the early detection of neurodegenerative diseases such as Alzheimer’s. Preventative monitoring approaches such as these could provide another avenue of detection to abet the provision of treatment.
Diagnostic Development
Towards Improved Biomarker Analysis and Validation
Key opinion leaders talk understanding the scientific and regulatory considerations for the qualification of biomarkers.
Diagnostic Development
New Gene Target Discovered for Aggressive Lung Cancer
Scientists at Northwestern Medicine propose a potential biomarker for identifying small-cell lung cancer.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery